Cash Flow Indoco Remedies Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-103.00
-75.00
124.00
192.00
236.00
132.00
Adjustment
249.00
183.00
137.00
120.00
87.00
109.00
Changes In working Capital
54.00
2.00
-87.00
-73.00
-108.00
-139.00
Cash Flow after changes in Working Capital
201.00
111.00
174.00
240.00
214.00
101.00
Cash Flow from Operating Activities
192.00
94.00
156.00
178.00
173.00
82.00
Cash Flow from Investing Activities
-101.00
-339.00
-433.00
-208.00
-121.00
-66.00
Cash Flow from Financing Activities
-76.00
241.00
280.00
22.00
-44.00
-29.00
Net Cash Inflow / Outflow
13.00
-2.00
3.00
-6.00
8.00
-14.00
Opening Cash & Cash Equivalents
12.00
14.00
10.00
17.00
9.00
23.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
25.00
12.00
14.00
10.00
17.00
9.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Indoco Remedies
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
-103.55
-7.37
-96.00
-1305.02%
Adjustment
249.98
16.53
233.00
1412.28%
Changes In working Capital
54.91
13.98
41.00
292.78%
Cash Flow after changes in Working Capital
201.34
23.14
178.00
770.10%
Cash Flow from Operating Activities
192.23
16.69
176.00
1051.77%
Cash Flow from Investing Activities
-101.61
-40.46
-61.00
-151.14%
Cash Flow from Financing Activities
-76.79
-1.06
-75.00
-7144.34%
Net Cash Inflow / Outflow
13.82
-24.82
37.00
155.68%
Opening Cash & Cash Equivalents
12.11
82.13
-70.00
-85.26%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
25.93
57.31
-32.00
-54.75%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 102.48% vs -39.41% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
192.23
94.94
102.48%
Footer loading
